unapproved drugs News
Most Popular unapproved drugs Story
FDA unapproved-drug campaign bites Lundbeck
A recent addition to the FDA list of drugs to be discontinued is Lundbeck's Mebaral (mephobarbital) 32-, 50- and 100-mg tablets. The drug, first approved for U.S. use in 1935, is a barbiturate used Read more...
Latest Headlines
- February 9, 2011
- August 11, 2010
- July 27, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
